SCHEMBL3413852

SCHEMBL3413852

Cc1cc(-c2ccnc(N)n2)ccc1N1CC2CC1CO2

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MAP3K12 Q12852 20/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2577774 0.82 MAP3K12 (0.49) MAP3K12
SCHEMBL3417266 0.77 KDM4E (0.48) —
SCHEMBL17076880 0.76 MAPT (0.42) MAP3K12
SCHEMBL4286106 0.75 STK17A (0.48) MAP3K12
SCHEMBL4276690 0.75 STK17A (0.48) MAP3K12
SCHEMBL3417553 0.73 KDM4E (0.42) —
SCHEMBL4283925 0.72 STK17A (0.46) MAP3K12
SCHEMBL4277427 0.72 STK17A (0.46) MAP3K12
SCHEMBL4284312 0.71 STK17A (0.48) —
SCHEMBL4281316 0.71 STK17A (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265607-A1 PYRIMIDINE-2-AMINE COMPOUNDS AND THEIR USE AS INHIBITORS OF JAK KINASES Rigel Pharmaceuticals, Inc. (US) 2010-12-29 — — EP disclosed
WO-2009103032-A1 PYRIMIDINE-2-AMINE COMPOUNDS AND THEIR USE AS INHIBITORS OF JAK KINASES RIGEL PHARMACEUTICALS, INC. (US) 2009-08-20 — — WO disclosed
Send feedback